Main Session
Sep
30
SS 40 - Hem 2: New Protocols, New Paradigms: Clinical Trials Shaping the Future of Hematologic RT
329 - Phase II Trial of Re-Priming Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Presenter(s)
Kiran Kumar, MD, MBA - UT Southwestern Medical Center, Dallas, TX